Moreover, since our results potentially link the NuRD complex to immune infiltration in hepatocellular carcinoma, targeting the HDAC activity within the NuRD complex may synergize with immune checkpoint inhibitor treatment. The gene discussed is HDAC9; the disease is hepatocellular carcinoma.